Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

 The Gynaecological Cancer Research Group

Understanding the fundamental of cancer cell behavior in order to improve effectiveness of clinical treatment

The Gynaecological Cancer Research Group (GCRG) is studying female reproductive cancers including the ovary, endometrium, cervix and vulva.

The laboratory research focus is on understanding the cell biology and behaviour of gynaecological cancer cells in 3D cell culture and animal models (chicken embryo and mouse).

Targeting cell signaling proteins including tyrosine kinases are the main focus of targeted anti-cancer drug portfolio.

Laboratory researchers are working closely with clinicians in order to translate research findings to be benefit for gynaecological cancer patients.

The clinical research is focusing on conducting clinical trails in gynaecological cancers. These clinical trials are carried out with the national and international collaborations.

Research Focus

  • Activity of Tyrosine kinases in Ovarian cancer
  • Effect of Ascitic fluid from ovarian cancer patient on ovarian cancer cells
  • Effect of natural food compounds on gynaecological cancers
  • Effect of cell bioimprint on cancer cell behavior and drug sensitivity
  • The biology of uterus microenvironment and success implantation
  • Nanoparticles, cell targeting and drug delivery
  • Cervical cancer and HPV vaccination

PhD, Master's and Honours opportunities

We are looking for highly motivated biomedical science student to do their PhD, Master's and Postgraduate degree with our group

Postgraduate opportunities in the Department of Obstetrics and Gynaecology

^ Top of Page